Mariner
ADMA icon

Mariner’s ADMA Biologics ADMA Stock Holding History

Mariner’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$266K Sell
29,554
-40,388
-58% -$637K ﹤0.01% 2973
2025
Q4 		$1.28M Buy
69,942
+31,569
+82% +$532K ﹤0.01% 1777
2025
Q3 		$563K Buy
38,373
+9,297
+32% +$159K ﹤0.01% 2333
2025
Q2 		$529K Buy
29,076
+7,584
+35% +$155K ﹤0.01% 2287
2025
Q1 		$426K Sell
21,492
-11,927
-36% -$206K ﹤0.01% 2333
2024
Q4 		$573K Buy
+33,419
New +$629K ﹤0.01% 2079

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mariner's ADMA Position: Q1 2026 in Review

Mariner reduced its ADMA Biologics (ADMA) stake by 58% in Q1 2026, selling an estimated $637K and leaving 29,554 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Mariner first reported a position in ADMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.28M in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Mariner held 29,554 shares of ADMA Biologics worth $266K as of Q1 2026.
  • Mariner sold 40,388 ADMA Biologics shares in Q1 2026, an estimated $637K.
  • ADMA Biologics made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2973 holding.
  • Mariner first reported a position in ADMA Biologics in Q4 2024 and has held it in 6 quarters since.
  • Mariner's ADMA Biologics position peaked at $1.28M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.